(MNOV:Consolidated Issue listed on NASDAQ Global Market)
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee, MediciNova Inc.
|Age||Total Calculated Compensation||This person is connected to 14 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Mr. Hiroaki Shigeta served as a Consultant of The Medicines Company from July 2006 to December 2007. Mr. Shigeta served as the Chief Executive Officer and President of Nippon Roche KK, a wholly-owned Japanese affiliate of Roche Holding of Switzerland, from 1993 to 2000. Since 2003, he served as US Head of Far East Relations of Hoffmann-La Roche, Inc. Mr. Shigeta served 18 years with Sandoz, leading divisions in Japan, Canada, Brazil, Switzerland and Portugal. From January ...
4275 Executive SquarePhone: 858-373-1500
La Jolla, California 92037
Board Members Memberships*
Independent Director, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
Haas School of Business
Momoyama Gakuin University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|